Literature DB >> 25080552

Group A streptococcus expresses a trio of surface proteins containing protective epitopes.

Shannon E Niedermeyer1, Thomas A Penfound1, Claudia Hohn1, Yi Li1, Ramin Homayouni2, Jingnan Zhao2, James B Dale3.   

Abstract

Group A streptococci (GAS) (Streptococcus pyogenes) are common causes of infections in humans for which there is no licensed vaccine. Decades of work has focused on the role of the surface M protein in eliciting type-specific protective immunity. Recent studies have identified additional surface proteins of GAS that contain opsonic epitopes. In the present study, we describe a serotype M65 GAS originally isolated during an epidemiologic study in Bamako, Mali, which simultaneously expressed M, M-related protein (Mrp), and streptococcal protective antigen (Spa) on the bacterial surface. The emm, mrp, and spa genes were sequenced from PCR amplicons derived from the M65 chromosome. Rabbit antisera raised against synthetic peptides copying the N-terminal regions of M, Mrp, and Spa were highly specific for each peptide, reacted with the surface of M65 GAS, and promoted bactericidal activity against the organism. A mixture of antisera against all three peptides was most effective in the bactericidal assays. Immunofluorescence microscopy revealed that the M, Mrp, and Spa antisera bound to the bacterial surface in the presence of human plasma proteins and resulted in the deposition of complement. Five additional spa genes were identified in the Mrp-positive GAS serotypes, and their sequences were determined. Our results indicate that there are multiple antigens on the surface of GAS that evoke antibodies that promote bacterial killing. A more complete understanding of the relative contributions of M, Mrp, and Spa in eliciting protective immunity may aid in the development of GAS vaccines with enhanced coverage and efficacy.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25080552      PMCID: PMC4266352          DOI: 10.1128/CVI.00448-14

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  21 in total

1.  Immunogenicity of a 26-valent group A streptococcal vaccine.

Authors:  Mary C Hu; Michael A Walls; Steven D Stroop; Mark A Reddish; Bernard Beall; James B Dale
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  Genetic correlates of throat and skin isolates of group A streptococci.

Authors:  D E Bessen; C M Sotir; T L Readdy; S K Hollingshead
Journal:  J Infect Dis       Date:  1996-04       Impact factor: 5.226

3.  Restricted deposition of C3 on M+ group A streptococci: correlation with resistance to phagocytosis.

Authors:  J Jacks-Weis; Y Kim; P P Cleary
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

4.  Spa contributes to the virulence of type 18 group A streptococci.

Authors:  D G McLellan; E Y Chiang; H S Courtney; D L Hasty; S C Wei; M C Hu; M A Walls; J J Bloom; J B Dale
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 5.  Group A streptococcal vaccines: paving a path for accelerated development.

Authors:  James B Dale; Vincent A Fischetti; Jonathan R Carapetis; Andrew C Steer; Samba Sow; Rajesh Kumar; Bongani M Mayosi; Fran A Rubin; Kim Mulholland; Joachim Maria Hombach; Florian Schödel; Ana Maria Henao-Restrepo
Journal:  Vaccine       Date:  2013-04-18       Impact factor: 3.641

6.  Potential coverage of a multivalent M protein-based group A streptococcal vaccine.

Authors:  James B Dale; Thomas A Penfound; Boubou Tamboura; Samba O Sow; James P Nataro; Milagritos Tapia; Karen L Kotloff
Journal:  Vaccine       Date:  2013-01-31       Impact factor: 3.641

7.  M-related protein (Mrp) contributes to group A streptococcal resistance to phagocytosis by human granulocytes.

Authors:  A Podbielski; N Schnitzler; P Beyhs; M D Boyle
Journal:  Mol Microbiol       Date:  1996-02       Impact factor: 3.501

Review 8.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

9.  Common protective antigens of group A streptococcal M proteins masked by fibrinogen.

Authors:  E Whitnack; J B Dale; E H Beachey
Journal:  J Exp Med       Date:  1984-04-01       Impact factor: 14.307

10.  The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci.

Authors:  K F Jones; V A Fischetti
Journal:  J Exp Med       Date:  1988-03-01       Impact factor: 14.307

View more
  2 in total

1.  Protective immunogenicity of group A streptococcal M-related proteins.

Authors:  James B Dale; Shannon E Niedermeyer; Tina Agbaosi; Nicholas D Hysmith; Thomas A Penfound; Claudia M Hohn; Matthew Pullen; Michael I Bright; Daniel S Murrell; Lori E Shenep; Harry S Courtney
Journal:  Clin Vaccine Immunol       Date:  2015-01-28

2.  Trivalent M-related protein as a component of next generation group A streptococcal vaccines.

Authors:  Harry S Courtney; Shannon E Niedermeyer; Thomas A Penfound; Claudia M Hohn; Adam Greeley; James B Dale
Journal:  Clin Exp Vaccine Res       Date:  2017-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.